Company Profile

Company Description

Contineum Therapeutics, Inc. is a biopharmaceutical firm focused on developing innovative therapies for neurological and inflammatory disorders. Leveraging cutting-edge research, the company aims to address unmet medical needs through novel small-molecule drugs. Its pipeline includes potential treatments for conditions like multiple sclerosis and depression, targeting key pathways in the central nervous system. By collaborating with leading researchers and institutions, the company strives to bring transformative therapies to patients, improving quality of life. With a strong emphasis on scientific rigor and clinical development, it is positioned as a promising player in the neurotherapeutics space.